Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
